REDWOOD CITY, Calif.--(BUSINESS WIRE)--EndoGastric Solutions (EGS) today announced that new U.S. clinical results for their third generation Transoral Incisionless Fundoplication (TIF2) procedure were presented during the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting April 14-17, in Washington, DC. Clinical outcomes data for over 100 patients treated with the TIF2 procedure were presented by Kevin Hoddinott, MD (Munroe Regional Medical Center, Ocala, FL), and William Barnes, MD (Livingston Hospital and Healthcare Services, Inc., Salem, KY).
